Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05569915 · ClinicalTrials.gov registry record · NA

Project QueST 2023: Queer Survivors of Trauma

A NA study of Stress Disorders, Post-Traumatic and Drinking Heavy, sponsored by Syracuse University.

Completed
Registry status
NA
Development phase
131
Enrollment target
1
Study location

NCT05569915 is a NA study of Stress Disorders, Post-Traumatic and Drinking Heavy that has completed, run by Syracuse University. The registered enrollment target is 131 participants, below the 154-participant average among 64 other Stress Disorders, Post-Traumatic trials with a reported enrollment target (15% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05569915, a NA study of Stress Disorders, Post-Traumatic and Drinking Heavy, has completed, sponsored by Syracuse University.

COMPLETED
Registry status
NA
Development phase
131 participants
Enrollment target
1
Study location

Study Summary

This study aims to test the initial efficacy of tailored online writing interventions specifically designed for sexual minority women, transgender individuals, and/or nonbinary people to target the primary outcomes: posttraumatic stress disorder (PTSD) symptom severity and hazardous drinking.

Interventions

  • BEHAVIORAL Control
  • BEHAVIORAL Trauma Expressive Writing
  • BEHAVIORAL Stigma Expressive Writing

Study Locations (1)

New York

  • Syracuse University - Syracuse

Trial Details

FieldValue
Enrollment Target 131 participants
Start Date 2023-06-01
Est. Completion 2024-11-30
Phase NA

Sponsor

Syracuse University

31 total trials

What the Registry Record Tells You About NCT05569915

The ClinicalTrials.gov registry entry for NCT05569915 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 131 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 154-participant average among 64 other Stress Disorders, Post-Traumatic trials with a reported enrollment target (15% lower). The listed sponsor is Syracuse University, which has 31 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Stress Disorders, Post-Traumatic appearing as the primary indexed condition, and to 3 interventions - of which Control is the first listed.

NCT05569915 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT05569915 about?

NCT05569915 is a clinical study titled "Project QueST 2023: Queer Survivors of Trauma". This study aims to test the initial efficacy of tailored online writing interventions specifically designed for sexual minority women, transgender individuals, and/or nonbinary people to target the primary outcomes: posttraumatic stress disorder (PTSD) symptom severity and hazardous drinking.

What is the current status of trial NCT05569915?

This trial is currently completed. It is a NA study. The enrollment target is 131 participants. The study started on 2023-06-01. Estimated completion is 2024-11-30.

What conditions does trial NCT05569915 study?

This clinical trial studies the following conditions: Stress Disorders, Post-Traumatic, Drinking Heavy.

What interventions are being tested in trial NCT05569915?

The interventions under investigation include: Control (BEHAVIORAL), Trauma Expressive Writing (BEHAVIORAL), Stigma Expressive Writing (BEHAVIORAL).

Who is sponsoring clinical trial NCT05569915?

This trial is sponsored by Syracuse University, which has 31 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05569915 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stress Disorders, Post-Traumatic

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.